In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay

Guiding AbbVie through an extraordinary decade-plus, riding the success of juggernaut inflammatory disease drug Humira and softening the landing upon its decline, Richard Gonzalez continues to reap the rewards as one of biopharma’s highest-paid execs.